Growth hormone is behind a lot of gym talk and a lot of anti-aging talk. Most compounds here ask the pituitary gland to release more of its own, and one is the hormone itself. The question to hold onto in every study: did a higher blood level turn into anything a person could feel?
CP-10
Ipamorelin + CJC-1295
โThe two-doorbell blendโ
๐กPicture this: The pituitary gland has more than one doorbell. This blend pairs a quick ring on one with a finger held down on the other, both asking for growth hormone.
๐ฌThe science: Ipamorelin switches on the ghrelin receptor, and half of it clears in about 2 hours. CJC-1295 copies part of GHRH, the brain's release signal, and its DAC hook latches onto a blood protein so it lingers for days.
๐The proof: On its own, CJC-1295 with DAC raised growth hormone 2 to 10 times for 6 days or more in healthy adults, and ipamorelin gave one spike that faded within hours. No published human study has tested the two together, and none measured muscle, fat or sleep.
๐Why people look at it: two signals adding up is an appealing idea, though the case for it comes from a 1990 study of a different peptide pairing.
Ipamorelin
โThe quick GH doorbellโ
๐กPicture this: One press on a doorbell. A single ring, the gland answers with one burst of growth hormone, and then the hallway goes quiet again.
๐ฌThe science: A five-piece lab-made peptide from Novo Nordisk that switches on the ghrelin receptor, which makes the pituitary release growth hormone. That receptor also sits in the gut, heart and other organs.
๐The proof: In healthy men, a single drip into a vein gave one growth hormone spike that peaked at about 40 minutes, then faded. The only published patient trial (114 adults after bowel surgery) found no statistically significant benefit. No published human study tested it under the skin, or measured muscle, fat or sleep.
๐Why people look at it: it is called "selective", meaning it left stress hormones alone, but that was shown in pigs and never in a person.
Tesamorelin
โThe full-length GHRH copyโ
๐กPicture this: The brain sends the pituitary a memo that says "release growth hormone". Tesamorelin is a photocopy of the whole memo with a protective cover stapled on, so it is harder to shred.
๐ฌThe science: It is the full 44-piece human GHRH plus a short fatty chain that makes it harder for a blood enzyme to break down. It contains no growth hormone. It tells the pituitary to release its own, which raises IGF-1.
๐The proof: It is FDA-approved as Egrifta for one use: extra belly fat in adults with HIV. Across two trials (806 people, 26 weeks), deep belly fat shrank about 15% more than on placebo. Weight barely moved, and the fat came back within about six months of stopping.
๐Why people look at it: it is one of the few compounds here with big placebo-controlled trials and an FDA approval behind it.
Sermorelin
โThe short GHRH copyโ
๐กPicture this: If GHRH is a 44-word memo telling the pituitary to release growth hormone, sermorelin is the first 29 words. Enough for the gland to get the message.
๐ฌThe science: It copies the first 29 of GHRH's 44 amino acids. It is a signal, not a replacement: the pituitary releases the body's own growth hormone, which then pushes up IGF-1.
๐The proof: It was FDA-approved for children who lacked growth hormone until 2009, when the maker ended it for reasons other than safety. In older adults, trials of 5 to 6 months saw men's growth hormone double and IGF-1 rise about 40%, with fat and lean-mass results the authors called preliminary. Sleep ratings got slightly worse.
๐Why people look at it: it once held an FDA approval, so it has a longer paper trail than most peptides in this section.
HGH 191AA
โThe growth signal itselfโ
๐กPicture this: The compounds above knock on the pituitary's door and ask. This one skips the door. It is the letter the gland would have sent, already written.
๐ฌThe science: Somatropin is a lab-made copy of the pituitary's own hormone: 191 amino acids in exactly the same order. It locks onto growth hormone receptors and switches on IGF-1.
๐The proof: A 2007 review of trials in healthy older adults (220 people on GH, about 27 weeks) found 2.1 kg more lean mass and 2.1 kg less fat, with weight unchanged and no clear gain in strength. Swelling, joint pain and carpal tunnel were common. The authors' verdict: not recommended as an anti-aging therapy.
๐Why people look at it: it is the original that the rest of this section tries to nudge, and it is FDA-approved for a short list of medical uses.
IGF-1 LR3
โThe brake-dodging growth signalโ
๐กPicture this: The body keeps its IGF-1 growth signal on a leash: binding proteins that hold it back. LR3 is the same signal in a slippery collar, built to wriggle loose.
๐ฌThe science: A modified copy of IGF-1 with 13 extra amino acids and one swap. It uses the same IGF-1 receptor, but natural IGF-1 grips the body's binding proteins about 1,000 times more tightly than LR3 does.
๐The proof: No human study has ever been published. In rats it looked up to 6 times stronger than natural IGF-1, yet it left the blood about 11 times faster. The same animal studies found low blood sugar, and faster tumor growth in rats with breast tumors.
๐Why people look at it: it was built in 1992 as a lab research tool, and the animal data shows both why it drew attention and why it worries people.